IMVT
Price
$29.90
Change
+$0.86 (+2.96%)
Updated
Nov 4 closing price
Capitalization
6.18B
4 days until earnings call
Intraday BUY SELL Signals
PTGX
Price
$140.03
Change
-$3.34 (-2.33%)
Updated
Nov 5, 11:27 AM (EDT)
Capitalization
9.28B
Earnings call today
Intraday BUY SELL Signals
Interact to see
Advertisement

IMVT vs PTGX

IMVT vs PTGX Comparison Chart in %
View a ticker or compare two or three
VS
IMVT vs. PTGX commentary
Nov 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMVT is a Buy and PTGX is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for IMVT with price predictions
Nov 04, 2026

IMVT's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for IMVT turned positive on October 22, 2026. Looking at past instances where IMVT's MACD turned positive, the stock continued to rise in 39 of 44 cases over the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IMVT's RSI Oscillator exited the oversold zone, 26 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.

The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on IMVT as a result. In 70 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.

Following a +5.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where IMVT advanced for three days, in 203 of 266 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

IMVT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 57 cases where IMVT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 81%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMVT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

The Aroon Indicator for IMVT entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 52 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.398) is normal, around the industry mean (2.904). P/E Ratio (-10.641) is within average values for comparable stocks, (-0.738). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.314) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron Profit vs. Risk Rating rating for this company is 58 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. IMVT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for PTGX with price predictions
Nov 04, 2026

PTGX in upward trend: price rose above 50-day moving average on November 04, 2026

PTGX moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend. In 26 of 29 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PTGX's RSI Oscillator exited the oversold zone, 17 of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.

The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on PTGX as a result. In 78 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.

The Moving Average Convergence Divergence (MACD) for PTGX just turned positive on October 22, 2026. Looking at past instances where PTGX's MACD turned positive, the stock continued to rise in 42 of 50 cases over the following month. The odds of a continued upward trend are 84%.

Following a +2.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where PTGX advanced for three days, in 234 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

PTGX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 57 cases where PTGX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 79%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PTGX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

The Aroon Indicator for PTGX entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 32 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. PTGX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.024) is normal, around the industry mean (2.904). PTGX has a moderately high P/E Ratio (117.516) as compared to the industry average of (-0.738). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.314) among similar stocks. P/S Ratio (34.130) is also within normal values, averaging (440.869).

FUNDAMENTALS RATINGS
IMVT vs PTGX: Fundamental Ratings
IMVT
PTGX
OUTLOOK RATING
1..100
941
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
97
Overvalued
PROFIT vs RISK RATING
1..100
583
SMR RATING
1..100
9859
PRICE GROWTH RATING
1..100
6138
P/E GROWTH RATING
1..100
2032
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMVT's Valuation (52) in the null industry is somewhat better than the same rating for PTGX (97) in the Biotechnology industry. This means that IMVT’s stock grew somewhat faster than PTGX’s over the last 12 months.

PTGX's Profit vs Risk Rating (3) in the Biotechnology industry is somewhat better than the same rating for IMVT (58) in the null industry. This means that PTGX’s stock grew somewhat faster than IMVT’s over the last 12 months.

PTGX's SMR Rating (59) in the Biotechnology industry is somewhat better than the same rating for IMVT (98) in the null industry. This means that PTGX’s stock grew somewhat faster than IMVT’s over the last 12 months.

PTGX's Price Growth Rating (38) in the Biotechnology industry is in the same range as IMVT (61) in the null industry. This means that PTGX’s stock grew similarly to IMVT’s over the last 12 months.

IMVT's P/E Growth Rating (20) in the null industry is in the same range as PTGX (32) in the Biotechnology industry. This means that IMVT’s stock grew similarly to PTGX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMVTPTGX
RSI
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 23 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
65%
COMPARISON
Comparison
Nov 05, 2026
Stock price -- (IMVT: $29.90 vs. PTGX: $143.37)
Brand notoriety: IMVT and PTGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMVT: 78% vs. PTGX: 92%
Market capitalization -- IMVT: $6.18B vs. PTGX: $9.28B
IMVT [@Biotechnology] is valued at $6.18B. PTGX’s [@Biotechnology] market capitalization is $9.28B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $139.16B. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMVT’s FA Score shows that 1 FA rating(s) are green while PTGX’s FA Score has 2 green FA rating(s).

  • IMVT’s FA Score: 1 green, 4 red.
  • PTGX’s FA Score: 2 green, 3 red.
According to our system of comparison, PTGX is a better buy in the long-term than IMVT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMVT’s TA Score shows that 5 TA indicator(s) are bullish while PTGX’s TA Score has 6 bullish TA indicator(s).

  • IMVT’s TA Score: 5 bullish, 3 bearish.
  • PTGX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, PTGX is a better buy in the short-term than IMVT.

Price Growth

IMVT (@Biotechnology) experienced а +1.63% price change this week, while PTGX (@Biotechnology) price change was +0.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.38%. For the same industry, the average monthly price growth was -11.00%, and the average quarterly price growth was -16.20%.

Reported Earning Dates

IMVT is expected to report earnings on Nov 09, 2026.

PTGX is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-3.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
+2.96%
ROIV - IMVT
64%
Loosely correlated
+6.08%
LXEO - IMVT
49%
Loosely correlated
+3.86%
KURA - IMVT
47%
Loosely correlated
-22.98%
PTGX - IMVT
46%
Loosely correlated
+2.23%
SYRE - IMVT
46%
Loosely correlated
-0.23%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EWX66.491.45
+2.23%
State Street SPDR S&P Emerging Markets Small Cap ETF (EWX)
SCDS73.520.81
+1.12%
JPMorgan Fundamental Data Science Small Core ETF (SCDS)
CGCB25.520.11
+0.43%
Capital Group Core Bond ETF (CGCB)
MYCJ24.120.08
+0.33%
State Street My2030 Corporate Bond ETF (MYCJ)
BEX17.07-2.50
-12.77%
Tradr 2X Long BE Daily ETF (BEX)